Salivary biomarkers in COVID-19 patients
The use of salivary biomarkers in diagnosis, treatment, and overall prognosis of coronavirus disease 2019 (COVID-19) has been developed recently. Salivary biomarkers are extremely promising as they are fast to obtain and involve noninvasive collection of specimens. Monitoring patients in real time i...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Journal of Family Medicine and Primary Care |
| Subjects: | |
| Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6778;epage=6782;aulast=Ubhale |
| _version_ | 1797954870840393728 |
|---|---|
| author | Rutuja Ubhale Sampada Dahake Priyanka Paul Madhu Kumar Gaurav Chhabra Amit Reche Anjali Bankar Simran Kriplani Barkha Adwani |
| author_facet | Rutuja Ubhale Sampada Dahake Priyanka Paul Madhu Kumar Gaurav Chhabra Amit Reche Anjali Bankar Simran Kriplani Barkha Adwani |
| author_sort | Rutuja Ubhale |
| collection | DOAJ |
| description | The use of salivary biomarkers in diagnosis, treatment, and overall prognosis of coronavirus disease 2019 (COVID-19) has been developed recently. Salivary biomarkers are extremely promising as they are fast to obtain and involve noninvasive collection of specimens. Monitoring patients in real time is necessary in this pandemic. Saliva is another biofluid with major advantages at the molecular level. Methods that detect viral presence in the host secretions measure the current infection by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), whereas the detection of human antibodies against SARS-CoV-2 evaluates the past exposure to the virus. There is an urgent need to increase the active research for the detection of SARS-CoV-2 in saliva because diagnostics may provide a reliable and cost-effective method and is suitable for the fast and early detection of COVID-19 infection. Salivary biomarkers have a potential to be a vital guide in determining coronavirus disease. Many people still do not get results of COVID-19 tests due to imbalance between supply and demand at large testing centers. The use of saliva has various advantages compared to collection of nasopharyngeal swabs. New techniques should be developed for detecting salivary biomarkers that help in diagnosis of COVID-19. |
| first_indexed | 2024-04-10T23:25:23Z |
| format | Article |
| id | doaj.art-81249b55dab943eca4da4e473c458a1f |
| institution | Directory Open Access Journal |
| issn | 2249-4863 |
| language | English |
| last_indexed | 2024-04-10T23:25:23Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Family Medicine and Primary Care |
| spelling | doaj.art-81249b55dab943eca4da4e473c458a1f2023-01-12T12:42:32ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632022-01-0111116778678210.4103/jfmpc.jfmpc_1569_21Salivary biomarkers in COVID-19 patientsRutuja UbhaleSampada DahakePriyanka Paul MadhuKumar Gaurav ChhabraAmit RecheAnjali BankarSimran KriplaniBarkha AdwaniThe use of salivary biomarkers in diagnosis, treatment, and overall prognosis of coronavirus disease 2019 (COVID-19) has been developed recently. Salivary biomarkers are extremely promising as they are fast to obtain and involve noninvasive collection of specimens. Monitoring patients in real time is necessary in this pandemic. Saliva is another biofluid with major advantages at the molecular level. Methods that detect viral presence in the host secretions measure the current infection by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), whereas the detection of human antibodies against SARS-CoV-2 evaluates the past exposure to the virus. There is an urgent need to increase the active research for the detection of SARS-CoV-2 in saliva because diagnostics may provide a reliable and cost-effective method and is suitable for the fast and early detection of COVID-19 infection. Salivary biomarkers have a potential to be a vital guide in determining coronavirus disease. Many people still do not get results of COVID-19 tests due to imbalance between supply and demand at large testing centers. The use of saliva has various advantages compared to collection of nasopharyngeal swabs. New techniques should be developed for detecting salivary biomarkers that help in diagnosis of COVID-19.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6778;epage=6782;aulast=Ubhalebiomarkercovid-19salivaryserum biomarkers |
| spellingShingle | Rutuja Ubhale Sampada Dahake Priyanka Paul Madhu Kumar Gaurav Chhabra Amit Reche Anjali Bankar Simran Kriplani Barkha Adwani Salivary biomarkers in COVID-19 patients Journal of Family Medicine and Primary Care biomarker covid-19 salivary serum biomarkers |
| title | Salivary biomarkers in COVID-19 patients |
| title_full | Salivary biomarkers in COVID-19 patients |
| title_fullStr | Salivary biomarkers in COVID-19 patients |
| title_full_unstemmed | Salivary biomarkers in COVID-19 patients |
| title_short | Salivary biomarkers in COVID-19 patients |
| title_sort | salivary biomarkers in covid 19 patients |
| topic | biomarker covid-19 salivary serum biomarkers |
| url | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6778;epage=6782;aulast=Ubhale |
| work_keys_str_mv | AT rutujaubhale salivarybiomarkersincovid19patients AT sampadadahake salivarybiomarkersincovid19patients AT priyankapaulmadhu salivarybiomarkersincovid19patients AT kumargauravchhabra salivarybiomarkersincovid19patients AT amitreche salivarybiomarkersincovid19patients AT anjalibankar salivarybiomarkersincovid19patients AT simrankriplani salivarybiomarkersincovid19patients AT barkhaadwani salivarybiomarkersincovid19patients |